GlassScriptPhysician profile
Victor Chiu
NPI 1285664375
$9,777.98
in general payments reported to CMS, 2019-2025
22 companies · $1,395 in 2025
The $1,395 reported for 2025 was more than what 84% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,578 · 2020: $219 · 2021: $1,582 · 2022: $1,466 · 2023: $2,207 · 2024: $1,331 · 2025: $1,395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,900 · Honoraria: $32.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,900.29 |
| Honoraria | $32.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $4,969.24 | 2019-2025 | Idosetr, Istent Infinite, Idose |
| Allergan, INC. | $1,091.88 | 2019-2021 | |
| Alcon Vision LLC | $1,037.15 | 2019-2025 | Clareon, Argos, Acrysof, Iq Restor |
| Johnson & Johnson Surgical Vision, INC. | $667.18 | 2019-2024 | Tecnis Iol, Tecnis Simplicity, Catalys System |
| Rxsight INC | $483.08 | 2022-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Abbvie INC. | $321.93 | 2023-2025 | Lumigan, Xen Glaucoma Treatment System |
| Sun Pharmaceutical Industries INC. | $191.92 | 2019-2023 | Cequa |
| Rayner Intraocular Lenses Limited | $153.59 | 2023-2025 | Rayone Emv, Rayone Aspheric, Rayone Spheric |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $150.40 | 2020-2021 | |
| Daiichi Sankyo INC. | $147.40 | 2025 | Datroway, Enhertu |
| Bausch & Lomb Americas INC. | $133.79 | 2022-2024 | Vyzulta |
| Biotissue Holdings INC. | $61.92 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $56.02 | 2019-2022 | |
| Staar Surgical Company | $54.90 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $51.48 | 2023 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $40.95 | 2022-2025 | Iyuzeh |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Heidelberg Engineering, INC. | $36.56 | 2025 | Spectralis |
| New World Medical,INC. | $34.05 | 2019 | |
| Oyster Point Pharma, INC. | $28.04 | 2022 | |
| Akorn Operating Company LLC | $14.06 | 2021 | |
| Iridex Corporation | $13.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victor Chiu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.